Report Detail

Request for Sample of this report

Chemical & Material Global Furosemide API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4628803
    • |
  • 26 September, 2025
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Furosemide API market size was valued at US$ 134 million in 2024 and is forecast to a readjusted size of USD 165 million by 2031 with a CAGR of 3.0% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Furosemide API is prepared by chemical synthesis, without preparation processing, and does not contain any pharmaceutical excipients. It is the basic ingredient of furosemide preparations (such as furosemide tablets, furosemide injection, etc.). Furosemide API is a white or off-white crystalline powder, odorless, slightly bitter, slightly soluble in ethanol, and almost insoluble in water. It is a potent diuretic that mainly acts on the thick ascending limb of the renal tubular loop of Henle, specifically inhibiting the Na⁺-K⁺-2Cl⁻ symporter on the luminal membrane side of the ascending limb of the loop of Henle, thereby inhibiting the reabsorption of NaCl, reducing the dilution and concentration function of the kidney, and excreting a large amount of urine close to isotonicity, producing a strong diuretic effect. It is often used in clinical practice to treat edematous diseases, hypertension, and prevent acute renal failure and other diseases.
As a classic and highly effective loop diuretic, furosemide is widely used in the treatment of heart failure, hypertension, renal edema, etc. Its API market presents a "mature but fiercely competitive" pattern. In terms of the current situation, the global furosemide API production capacity is concentrated in emerging market countries such as China and India, among which China accounts for about 60% of the export share, and dominates the low-end and mid-end markets with large-scale production and cost advantages; however, the European and American markets have stricter requirements for API quality standards (such as ICH Q7, cGMP), which has promoted domestic companies to accelerate technology upgrades. Some leading manufacturers have passed FDA/EDQM certification and entered the high-end supply chain. The current dynamic trends show that: 1) formulation innovation drives demand. With the development of compound preparations (such as furosemide + spironolactone) and new drug delivery systems (such as sustained-release pellets), the purity of APIs (need to reach more than 99.5%) and the stability of crystal forms have become the focus of differentiated competition; 2) With the rise of green synthesis technology, traditional chemical synthesis methods are facing environmental pressure. Enterprises are exploring processes such as biocatalysis and continuous flow reaction to reduce the discharge of "three wastes". For example, a company has increased the recovery rate of by-products to 90% through enzyme catalysis technology; 3) Supply chain fluctuations have intensified. Geopolitical and energy crises have led to price fluctuations in basic chemical raw materials (such as chlorosulfonic acid and aniline), forcing companies to diversify risks through vertical integration (self-built intermediate workshops) or regional layout (such as building factories in Southeast Asia); 4) The centralized procurement policy reshapes the pattern. In China's seventh batch of national centralized procurement, the price of furosemide tablets dropped by more than 80%, forcing API companies to transform to high value-added fields (such as API + formulation integration). In the future, the furosemide API market will show a "stronger and stronger" trend, and technical barriers and compliance capabilities will become the core moat of enterprises.
This report is a detailed and comprehensive analysis for global Furosemide API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Furosemide API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Furosemide API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Furosemide API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Furosemide API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Furosemide API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Furosemide API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kalintis Healthcare Pvt Ltd, Curia India Private Limited, Sri Krishna Pharmaceuticals Ltd, Euroapi Germany Gmbh, Ipca Laboratories Ltd, Fis Fabbrica Italiana Sintetici Spa, Olon S.P.A., Teva Pharmaceutical Industries Ltd, Mangalam Drugs & Organics Ltd., Assia Chemical Industries Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Furosemide API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Injection
Tablet
Solution
Major players covered
Kalintis Healthcare Pvt Ltd
Curia India Private Limited
Sri Krishna Pharmaceuticals Ltd
Euroapi Germany Gmbh
Ipca Laboratories Ltd
Fis Fabbrica Italiana Sintetici Spa
Olon S.P.A.
Teva Pharmaceutical Industries Ltd
Mangalam Drugs & Organics Ltd.
Assia Chemical Industries Ltd
Guangzhou Baiyunshan Pharmaceutical
Beijing Taiyang Pharmaceutical Industry
NORTHEAST Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Furosemide API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Furosemide API, with price, sales quantity, revenue, and global market share of Furosemide API from 2020 to 2025.
Chapter 3, the Furosemide API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Furosemide API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Furosemide API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Furosemide API.
Chapter 14 and 15, to describe Furosemide API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Furosemide API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Furosemide API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Injection
    • 1.4.3 Tablet
    • 1.4.4 Solution
  • 1.5 Global Furosemide API Market Size & Forecast
    • 1.5.1 Global Furosemide API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Furosemide API Sales Quantity (2020-2031)
    • 1.5.3 Global Furosemide API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Kalintis Healthcare Pvt Ltd
    • 2.1.1 Kalintis Healthcare Pvt Ltd Details
    • 2.1.2 Kalintis Healthcare Pvt Ltd Major Business
    • 2.1.3 Kalintis Healthcare Pvt Ltd Furosemide API Product and Services
    • 2.1.4 Kalintis Healthcare Pvt Ltd Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Kalintis Healthcare Pvt Ltd Recent Developments/Updates
  • 2.2 Curia India Private Limited
    • 2.2.1 Curia India Private Limited Details
    • 2.2.2 Curia India Private Limited Major Business
    • 2.2.3 Curia India Private Limited Furosemide API Product and Services
    • 2.2.4 Curia India Private Limited Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Curia India Private Limited Recent Developments/Updates
  • 2.3 Sri Krishna Pharmaceuticals Ltd
    • 2.3.1 Sri Krishna Pharmaceuticals Ltd Details
    • 2.3.2 Sri Krishna Pharmaceuticals Ltd Major Business
    • 2.3.3 Sri Krishna Pharmaceuticals Ltd Furosemide API Product and Services
    • 2.3.4 Sri Krishna Pharmaceuticals Ltd Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sri Krishna Pharmaceuticals Ltd Recent Developments/Updates
  • 2.4 Euroapi Germany Gmbh
    • 2.4.1 Euroapi Germany Gmbh Details
    • 2.4.2 Euroapi Germany Gmbh Major Business
    • 2.4.3 Euroapi Germany Gmbh Furosemide API Product and Services
    • 2.4.4 Euroapi Germany Gmbh Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Euroapi Germany Gmbh Recent Developments/Updates
  • 2.5 Ipca Laboratories Ltd
    • 2.5.1 Ipca Laboratories Ltd Details
    • 2.5.2 Ipca Laboratories Ltd Major Business
    • 2.5.3 Ipca Laboratories Ltd Furosemide API Product and Services
    • 2.5.4 Ipca Laboratories Ltd Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Ipca Laboratories Ltd Recent Developments/Updates
  • 2.6 Fis Fabbrica Italiana Sintetici Spa
    • 2.6.1 Fis Fabbrica Italiana Sintetici Spa Details
    • 2.6.2 Fis Fabbrica Italiana Sintetici Spa Major Business
    • 2.6.3 Fis Fabbrica Italiana Sintetici Spa Furosemide API Product and Services
    • 2.6.4 Fis Fabbrica Italiana Sintetici Spa Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
  • 2.7 Olon S.P.A.
    • 2.7.1 Olon S.P.A. Details
    • 2.7.2 Olon S.P.A. Major Business
    • 2.7.3 Olon S.P.A. Furosemide API Product and Services
    • 2.7.4 Olon S.P.A. Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Olon S.P.A. Recent Developments/Updates
  • 2.8 Teva Pharmaceutical Industries Ltd
    • 2.8.1 Teva Pharmaceutical Industries Ltd Details
    • 2.8.2 Teva Pharmaceutical Industries Ltd Major Business
    • 2.8.3 Teva Pharmaceutical Industries Ltd Furosemide API Product and Services
    • 2.8.4 Teva Pharmaceutical Industries Ltd Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.9 Mangalam Drugs & Organics Ltd.
    • 2.9.1 Mangalam Drugs & Organics Ltd. Details
    • 2.9.2 Mangalam Drugs & Organics Ltd. Major Business
    • 2.9.3 Mangalam Drugs & Organics Ltd. Furosemide API Product and Services
    • 2.9.4 Mangalam Drugs & Organics Ltd. Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Mangalam Drugs & Organics Ltd. Recent Developments/Updates
  • 2.10 Assia Chemical Industries Ltd
    • 2.10.1 Assia Chemical Industries Ltd Details
    • 2.10.2 Assia Chemical Industries Ltd Major Business
    • 2.10.3 Assia Chemical Industries Ltd Furosemide API Product and Services
    • 2.10.4 Assia Chemical Industries Ltd Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Assia Chemical Industries Ltd Recent Developments/Updates
  • 2.11 Guangzhou Baiyunshan Pharmaceutical
    • 2.11.1 Guangzhou Baiyunshan Pharmaceutical Details
    • 2.11.2 Guangzhou Baiyunshan Pharmaceutical Major Business
    • 2.11.3 Guangzhou Baiyunshan Pharmaceutical Furosemide API Product and Services
    • 2.11.4 Guangzhou Baiyunshan Pharmaceutical Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
  • 2.12 Beijing Taiyang Pharmaceutical Industry
    • 2.12.1 Beijing Taiyang Pharmaceutical Industry Details
    • 2.12.2 Beijing Taiyang Pharmaceutical Industry Major Business
    • 2.12.3 Beijing Taiyang Pharmaceutical Industry Furosemide API Product and Services
    • 2.12.4 Beijing Taiyang Pharmaceutical Industry Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Beijing Taiyang Pharmaceutical Industry Recent Developments/Updates
  • 2.13 NORTHEAST Pharmaceutical Group
    • 2.13.1 NORTHEAST Pharmaceutical Group Details
    • 2.13.2 NORTHEAST Pharmaceutical Group Major Business
    • 2.13.3 NORTHEAST Pharmaceutical Group Furosemide API Product and Services
    • 2.13.4 NORTHEAST Pharmaceutical Group Furosemide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 NORTHEAST Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Furosemide API by Manufacturer

  • 3.1 Global Furosemide API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Furosemide API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Furosemide API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Furosemide API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Furosemide API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Furosemide API Manufacturer Market Share in 2024
  • 3.5 Furosemide API Market: Overall Company Footprint Analysis
    • 3.5.1 Furosemide API Market: Region Footprint
    • 3.5.2 Furosemide API Market: Company Product Type Footprint
    • 3.5.3 Furosemide API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Furosemide API Market Size by Region
    • 4.1.1 Global Furosemide API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Furosemide API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Furosemide API Average Price by Region (2020-2031)
  • 4.2 North America Furosemide API Consumption Value (2020-2031)
  • 4.3 Europe Furosemide API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Furosemide API Consumption Value (2020-2031)
  • 4.5 South America Furosemide API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Furosemide API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Furosemide API Sales Quantity by Type (2020-2031)
  • 5.2 Global Furosemide API Consumption Value by Type (2020-2031)
  • 5.3 Global Furosemide API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Furosemide API Sales Quantity by Application (2020-2031)
  • 6.2 Global Furosemide API Consumption Value by Application (2020-2031)
  • 6.3 Global Furosemide API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Furosemide API Sales Quantity by Type (2020-2031)
  • 7.2 North America Furosemide API Sales Quantity by Application (2020-2031)
  • 7.3 North America Furosemide API Market Size by Country
    • 7.3.1 North America Furosemide API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Furosemide API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Furosemide API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Furosemide API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Furosemide API Market Size by Country
    • 8.3.1 Europe Furosemide API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Furosemide API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Furosemide API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Furosemide API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Furosemide API Market Size by Region
    • 9.3.1 Asia-Pacific Furosemide API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Furosemide API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Furosemide API Sales Quantity by Type (2020-2031)
  • 10.2 South America Furosemide API Sales Quantity by Application (2020-2031)
  • 10.3 South America Furosemide API Market Size by Country
    • 10.3.1 South America Furosemide API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Furosemide API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Furosemide API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Furosemide API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Furosemide API Market Size by Country
    • 11.3.1 Middle East & Africa Furosemide API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Furosemide API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Furosemide API Market Drivers
  • 12.2 Furosemide API Market Restraints
  • 12.3 Furosemide API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Furosemide API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Furosemide API
  • 13.3 Furosemide API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Furosemide API Typical Distributors
  • 14.3 Furosemide API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Furosemide API. Industry analysis & Market Report on Furosemide API is a syndicated market report, published as Global Furosemide API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Furosemide API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo